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In this study anticonvulsants were the group of drugs most likely to cause a detectable drug reaction. This is probably related to the narrow therapeutic range of anticonvulsants. It may also be partly explained by the bias towards patients with neurological disorders in the study. These children were more severely ill than other children and thus at greater risk from a drug reaction. 2
That 6 of the 15 adverse drug reactions were preventable suggests that doctors need to be more careful in the drugs they prescribe-asking themselves whether the drug is necessary or not, whether the dosage is correct, and whether any drug interaction is likely. The results suggest that if these simple measures were carried out, fewer iatrogenic problems would arise. SUMMARY A boy who had previously had a cleft lip and palate repaired and bilateral orchiopexies presented at 16 years of age with delayed puberty. Isolated gonadotrophin deficiency and testicular hyporesponsiveness to human chorionic gonadotrophin were found. The possibility of bilateral cryptorchidism due to gonadotrophin deficiency should be considered in boys with either cleft lip or palate, or both.
Case report
A 16 year old boy was investigated for delayed puberty and short stature. He was born in July 1967 with a cleft lip and palate which were repaired at the ages of 3 months and 15 months respectively. The only details of his previous growth available were a height of 131 cm (25th centile) at 9-8 years and 140 cm (25th centile) at 11-5 years. He developed moderately severe asthma at 8 years of age and because of acute exacerbations required brief admissions to hospital on three occasions. His only exposure to corticosteroids was a 10 day course of hydrocortisone and prednisone during each of the latter two admissions to hospital. Bilateral cryptorchidism was not diagnosed until 9 years of age; right and then left orchiopexies were performed at ages 10 and 12 years. A nasal septoplasty was necessary at 15 years of age. He has been asymptomatic apart from occasional rhinitis and wheezing for which he has continuously taken bronchodilators and sodium cromoglycate. There is no family history of short stature, delayed puberty, or atopy.
Physical examination showed a short prepubertal boy of normal habitus and intellect with both height (156-5 cm) and weight (45-4 kg) below the third centile. He had bilateral, partial nasal obstruction and some degree of hyposmia. He seemed neurologically intact; his optic fundi, visual fields, and colour vision were normal. There was no physical Cleft palate and gonadotrophin deficiency 581 deformity due to chronic asthma. His penis measured 3-0 cm, both testes were in a high scrotal position, and each was 2 to 3 ml in volume. No secondary sexual characteristics were evident.
Investigations
The skull radiograph was normal. His bone age (according to the method of Greulich and Pyle) was reported to be between 12 and 13 years. His karyotype was 46, XY. Routine haematological and serum biochemical analyses were normal as were his thyroid function tests. Anterior pituitary function was assessed using a combined insulin tolerance, thyrotrophin releasing hormone, and luteinising hormone releasing hormone test similar to the protocol described by Savage et al. The results of this test (Table 1) were normal except for the poor gonadotrophin responses. Presumptive hypogonadotrophic hypogonadism was confirmed by a four hour luteinising hormone releasing hormone infusion (50 gg/hr).2 The peak plasma follicle stimulating hormone and luteinising hormone concentrations during this test were 2-7 U/l and 1-7 U/l respectively; luteinising hormone was not detected (less than 0-9 U/l) after the 120 minute sample. A five day human chorionic gonadotrophin stimulation test was conducted on two occasions. On the first occasion an injection of human chorionic gonadotrophin (1500 U) was given daily for four days. The second test was performed two months later when 5000 U was injected daily for four days. The plasma testosterone concentration was measured immediately before the first injection of human chorionic gonadotrophin, then again on days three and five of each test. These results are presented in 
